These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 8993088

  • 1. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 2. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 3. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD, Heiser JF, Shrivastava RK, Weiss KJ, Smith WT, Sitsen JM, Gibertini M.
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [Abstract] [Full Text] [Related]

  • 4. Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial.
    Amsterdam JD, Brunswick DJ, Gibertini M.
    J Psychiatr Res; 2004 Mar; 38(3):259-65. PubMed ID: 15003431
    [Abstract] [Full Text] [Related]

  • 5. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 6. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA, Reimitz PE, Sennef C.
    Psychopharmacol Bull; 1997 Mar; 33(1):41-51. PubMed ID: 9133750
    [Abstract] [Full Text] [Related]

  • 7. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990 Mar; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 8. A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients.
    Wilcox CS, Ferguson JM, Dale JL, Heiser JF.
    Psychopharmacol Bull; 1996 Mar; 32(3):335-42. PubMed ID: 8961776
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [Abstract] [Full Text] [Related]

  • 10. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 11. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR.
    J Clin Psychiatry; 1996 Feb; 57 Suppl 2():15-8. PubMed ID: 8626358
    [Abstract] [Full Text] [Related]

  • 12. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N, Ravic M, Bizière K.
    Drugs Exp Clin Res; 1987 Feb; 13(7):435-42. PubMed ID: 3308390
    [Abstract] [Full Text] [Related]

  • 13. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 Feb; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 14. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 15. Nefazodone: aspects of efficacy.
    Rickels K, Robinson DS, Schweizer E, Marcus RN, Roberts DL.
    J Clin Psychiatry; 1995 Feb; 56 Suppl 6():43-6. PubMed ID: 7649973
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [Abstract] [Full Text] [Related]

  • 17. Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study.
    Bielski RJ, Cunningham L, Horrigan JP, Londborg PD, Smith WT, Weiss K.
    J Clin Psychiatry; 2008 Apr; 69(4):571-7. PubMed ID: 18373383
    [Abstract] [Full Text] [Related]

  • 18. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [Abstract] [Full Text] [Related]

  • 19. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.
    Depress Anxiety; 2007 Jul; 24(1):1-14. PubMed ID: 16894619
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA.
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.